PharmaCyte Biotech Inc
Research PharmaCyte Biotech Inc (PMCB) on Bullrun: market cap USD 5.79M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPMCB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.79M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 4.39M
- Free cash flow-USD 1.39M
Valuation Snapshot
latest market cap is USD 5.79M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | USD 30.66M | -USD 4.52M | n/a | 3.19 | USD 15.17M | n/a | USD 51.89M |
| FY2024 | USD 0 | USD 333.76K | -USD 1.94M | n/a | -1.8 | USD 50.18M | n/a | USD 27.65M |
| FY2023 | USD 0 | -USD 4.32M | n/a | n/a | -0.22 | USD 68.04M | n/a | USD 72.69M |
| FY2022 | USD 0 | -USD 4.24M | n/a | n/a | -0.27 | USD 85.40M | n/a | USD 89.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 5.79M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.30M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 10.94M | 2.9 | n/a | n/a |
| 2023 | 2023-12-29 | USD 18.61M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 54.87M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 51.79M | n/a | n/a | n/a |
About PharmaCyte Biotech Inc
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PharmaCyte Biotech Inc's market cap?
PharmaCyte Biotech Inc's market capitalization is USD 5.79M.
What does PharmaCyte Biotech Inc do?
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors.